MT1-MMP protects breast carcinoma cells against type I collagen-induced apoptosis

As invading breast carcinoma cells breach their underlying basement membrane, they become confronted with a dense three-dimensional reactive stroma dominated by type I collagen. To develop metastatic capabilities, invading tumor cells must acquire the capacity to negotiate this novel microenvironment. Collagen influences the fate of epithelial cells by inducing apoptosis. However, the mechanisms used by invading tumor cells to evade collagen-induced apoptosis remain to be defined. We demonstrate that membrane type-1 matrix metalloproteinase (MT1-MMP/MMP-14) confers breast cancer cells with the ability to escape apoptosis when embedded in a collagen gel and after orthotopic implantation in vivo. In the absence of MMP-14-dependent proteolysis, type I collagen triggers apoptosis by inducing the expression of the pro-apoptotic Bcl-2-interacting killer in luminal-like breast cancer cells. These findings reveal a new mechanism whereby MMP-14 activity promotes tumor progression by circumventing apoptosis.

[1]  J. Foidart,et al.  Regulation of vimentin by SIP1 in human epithelial breast tumor cells , 2006, Oncogene.

[2]  K. Coser,et al.  The Bik BH3-only protein is induced in estrogen-starved and antiestrogen-exposed breast cancer cells and provokes apoptosis. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[3]  Steven Shapiro,et al.  Tumor cell traffic through the extracellular matrix is controlled by the membrane-anchored collagenase MT1-MMP , 2004, The Journal of cell biology.

[4]  C. Overall,et al.  Matrix metalloproteinases: what do they not do? New substrates and biological roles identified by murine models and proteomics. , 2010, Biochimica et biophysica acta.

[5]  S. Miyamoto,et al.  Proteolytic activation of heparin‐binding EGF‐like growth factor by membrane‐type matrix metalloproteinase‐1 in ovarian carcinoma cells , 2011, Cancer science.

[6]  R A Knight,et al.  Guidelines for the use and interpretation of assays for monitoring cell death in higher eukaryotes , 2009, Cell Death and Differentiation.

[7]  S. Weiss,et al.  A cancer cell metalloprotease triad regulates the basement membrane transmigration program. , 2006, Genes & development.

[8]  Gema Moreno-Bueno,et al.  Epithelial-mesenchymal transition in breast cancer relates to the basal-like phenotype. , 2008, Cancer research.

[9]  D. Hanahan,et al.  The Hallmarks of Cancer , 2000, Cell.

[10]  M. Hung,et al.  Systemic tumor suppression by the proapoptotic gene bik. , 2002, Cancer research.

[11]  C. López-Otín,et al.  The regulatory crosstalk between kinases and proteases in cancer , 2010, Nature Reviews Cancer.

[12]  J. Ryerse,et al.  BAX/BAK–Independent Mitoptosis during Cell Death Induced by Proteasome Inhibition? , 2009, Molecular Cancer Research.

[13]  Kakajan Komurov,et al.  Core epithelial-to-mesenchymal transition interactome gene-expression signature is associated with claudin-low and metaplastic breast cancer subtypes , 2010, Proceedings of the National Academy of Sciences.

[14]  M. Duffy,et al.  Matrix metalloproteinase expression and outcome in patients with breast cancer: analysis of a published database. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[15]  D. Gingras,et al.  Emerging concepts in the regulation of membrane-type 1 matrix metalloproteinase activity. , 2010, Biochimica et biophysica acta.

[16]  Y. Itoh,et al.  Matrix metalloproteinases in cancer. , 2002, Essays in biochemistry.

[17]  C. Overall,et al.  Pharmacoproteomics of a Metalloproteinase Hydroxamate Inhibitor in Breast Cancer Cells: Dynamics of Membrane Type 1 Matrix Metalloproteinase-Mediated Membrane Protein Shedding , 2008, Molecular and Cellular Biology.

[18]  John D. Minna,et al.  Molecular Profiling of Breast Cancer Cell Lines Defines Relevant Tumor Models and Provides a Resource for Cancer Gene Discovery , 2009, PloS one.

[19]  S. Weiss,et al.  Induction of a MT1-MMP and MT2-MMP-dependent basement membrane transmigration program in cancer cells by Snail1 , 2009, Proceedings of the National Academy of Sciences.

[20]  S. Weiss,et al.  Matrix Metalloproteinases (MMPs) Regulate Fibrin-invasive Activity via MT1-MMP–dependent and –independent Processes , 2002, The Journal of experimental medicine.

[21]  H. Birkedal‐Hansen.  Catabolism and turnover of collagens: collagenases. , 1987, Methods in enzymology.

[22]  Stephen J. Weiss,et al.  Protease-dependent versus -independent cancer cell invasion programs: three-dimensional amoeboid movement revisited , 2009, The Journal of cell biology.

[23]  Z. Werb,et al.  Matrix Metalloproteinases: Regulators of the Tumor Microenvironment , 2010, Cell.

[24]  R. Tibshirani,et al.  Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[25]  J. Foidart,et al.  Up-regulation of Vascular Endothelial Growth Factor-A by Active Membrane-type 1 Matrix Metalloproteinase through Activation of Src-Tyrosine Kinases* , 2004, Journal of Biological Chemistry.

[26]  M. Stack,et al.  Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis. , 2008, Seminars in cell & developmental biology.

[27]  D. Cheresh,et al.  Integrin alpha v beta 3 rescues melanoma cells from apoptosis in three-dimensional dermal collagen. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[28]  S. Miyamoto,et al.  Integrin signal masks growth-promotion activity of HB-EGF in monolayer cell cultures , 2009, Journal of Cell Science.

[29]  Raghu Kalluri,et al.  Fibroblasts in cancer , 2006, Nature Reviews Cancer.

[30]  Z. Werb,et al.  New functions for the matrix metalloproteinases in cancer progression , 2002, Nature Reviews Cancer.

[31]  I. Mian,et al.  Tissue architecture: the ultimate regulator of breast epithelial function. , 2003, Current opinion in cell biology.

[32]  J. Keski‐Oja,et al.  Regulation of Membrane-type-1 Matrix Metalloproteinase Activity by Its Cytoplasmic Domain* , 2000, The Journal of Biological Chemistry.

[33]  Kenneth M. Yamada,et al.  Modeling Tissue Morphogenesis and Cancer in 3D , 2007, Cell.

[34]  Z. Werb,et al.  How matrix metalloproteinases regulate cell behavior. , 2001, Annual review of cell and developmental biology.

[35]  P. Bouillet,et al.  BH3-only proteins and their roles in programmed cell death , 2008, Oncogene.

[36]  M. Ringuette,et al.  Collagen I but not Matrigel matrices provide an MMP-dependent barrier to ovarian cancer cell penetration , 2008, BMC Cancer.

[37]  A. Noël,et al.  Matrix metalloproteinases at cancer tumor-host interface. , 2008, Seminars in cell & developmental biology.

[38]  J. Risteli,et al.  Aberrant type I and type III collagen gene expression in human breast cancer in vivo , 1998, The Journal of pathology.

[39]  K. Weinberg,et al.  Contact with fibrillar collagen inhibits melanoma cell proliferation by up-regulating p27KIP1. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[40]  Richard O. Hynes,et al.  The Extracellular Matrix: Not Just Pretty Fibrils , 2009, Science.

[41]  Olga Antipova,et al.  Collagen fibril architecture, domain organization, and triple-helical conformation govern its proteolysis , 2008, Proceedings of the National Academy of Sciences.

[42]  Stephen J. Weiss,et al.  Regulation of Cell Invasion and Morphogenesis in a Three-Dimensional Type I Collagen Matrix by Membrane-Type Matrix Metalloproteinases 1, 2, and 3 , 2000, The Journal of cell biology.

[43]  M. Roizen,et al.  Hallmarks of Cancer: The Next Generation , 2012 .

[44]  Tae-You Kim,et al.  Epigenomic profiling reveals novel and frequent targets of aberrant DNA methylation-mediated silencing in malignant glioma. , 2006, Cancer research.

[45]  Elise C. Kohn,et al.  The microenvironment of the tumour–host interface , 2001, Nature.

[46]  C. Overall,et al.  TIMP Independence of Matrix Metalloproteinase (MMP)-2 Activation by Membrane Type 2 (MT2)-MMP Is Determined by Contributions of Both the MT2-MMP Catalytic and Hemopexin C Domains* , 2006, Journal of Biological Chemistry.

[47]  S. Hattori,et al.  Keratinocyte apoptosis on type I collagen gel caused by lack of laminin 5/10/11 deposition and Akt signaling. , 2002, Experimental cell research.

[48]  S. Eccles,et al.  Control of lymphatic and hematogenous metastasis of a rat mammary carcinoma by the matrix metalloproteinase inhibitor batimastat (BB-94). , 1996, Cancer research.

[49]  S. Weiss,et al.  Membrane Type I Matrix Metalloproteinase Usurps Tumor Growth Control Imposed by the Three-Dimensional Extracellular Matrix , 2003, Cell.

[50]  P. Chambon,et al.  Membrane-type matrix metalloproteinase (MT-MMP) gene is expressed in stromal cells of human colon, breast, and head and neck carcinomas. , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[51]  B. Dörken,et al.  Loss of the tissue-specific proapoptotic BH3-only protein Nbk/Bik is a unifying feature of renal cell carcinoma , 2006, Cell Death and Differentiation.

[52]  Y. Okada,et al.  Membrane Type 1 Matrix Metalloproteinase Digests Interstitial Collagens and Other Extracellular Matrix Macromolecules* , 1997, The Journal of Biological Chemistry.

[53]  M. Sogayar,et al.  Correlation between MMPs and their inhibitors in breast cancer tumor tissue specimens and in cell lines with different metastatic potential , 2009, BMC Cancer.

[54]  S. Weiss,et al.  Secreted Versus Membrane-anchored Collagenases , 2009, The Journal of Biological Chemistry.

[55]  R. Weinberg,et al.  Transitions between epithelial and mesenchymal states: acquisition of malignant and stem cell traits , 2009, Nature Reviews Cancer.

[56]  L. Devy,et al.  MT1‐MMP expression promotes tumor growth and angiogenesis through an up‐regulation of vascular endothelial growth factor expression , 2002, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[57]  Hiroshi Sato,et al.  Roles of membrane‐type matrix metalloproteinase‐1 in tumor invasion and metastasis , 2005, Cancer science.

[58]  Gillian Murphy,et al.  Structure and function of matrix metalloproteinases and TIMPs. , 2006, Cardiovascular research.

[59]  Roman Rouzier,et al.  Breast Cancer Molecular Subtypes Respond Differently to Preoperative Chemotherapy , 2005, Clinical Cancer Research.

[60]  M. Weller,et al.  Adenoviral natural born killer gene therapy for malignant glioma. , 2003, Human gene therapy.

[61]  R. Weinberg,et al.  Epithelial Mesenchymal Transition Traits in Human Breast Cancer Cell Lines Parallel the CD44hi/CD24lo/- Stem Cell Phenotype in Human Breast Cancer , 2010, Journal of Mammary Gland Biology and Neoplasia.

[62]  R. M. Simpson,et al.  Metastatic growth from dormant cells induced by a col-I-enriched fibrotic environment. , 2010, Cancer research.

[63]  S. Weiss,et al.  Matrix Metalloproteinases Regulate Neovascularization by Acting as Pericellular Fibrinolysins , 1998, Cell.

[64]  Wenjie Bao,et al.  Integrin (cid:1) v-mediated inactivation of p53 controls a MEK1-dependent melanoma cell survival pathway in three-dimensional collagen , 2022 .

[65]  G. Shore,et al.  BH3-only BIK Regulates BAX,BAK-dependent Release of Ca2+ from Endoplasmic Reticulum Stores and Mitochondrial Apoptosis during Stress-induced Cell Death* , 2005, Journal of Biological Chemistry.

[66]  G. Chinnadurai,et al.  BIK, the founding member of the BH3-only family proteins: mechanisms of cell death and role in cancer and pathogenic processes , 2008, Oncogene.